Navigation Links
Helix BioPharma Corp. Announces Fiscal Q1 2010 Results
Date:12/9/2009

AURORA, Ontario, Dec. 9 /PRNewswire-FirstCall/ -- Helix BioPharma Corp. (TSX, FSE: HBP; OTCQX: HXBPF) today announced financial results for the first quarter ended October 31, 2009.

FIRST QUARTER 2010 HIGHLIGHTS

DOS47/L-DOS47

  • Helix announced that a pre-IND meeting had been held for L-DOS47 with the U.S. Food and Drug Administration ("FDA") in which the FDA generally agreed with Helix's proposed remaining non-clinical pharmacology and toxicology studies as well as its remaining GMP manufacturing program initiatives prior to IND filing.
  • Helix announced plans to conduct a Phase I/II clinical study of non-small cell lung cancer ("NSCLC") patients in Poland. Helix continues to develop these plans together with key opinion leader clinicians and prospective contract research organizations. The study is expected to run concurrently with the U.S. Phase I study in refractory solid tumor patients. The timing of both studies will be contingent on the timing of regulatory approvals of the trials as well as obtaining additional capital. The Company continues to plan to file an investigational new drug submission ("IND") and clinical trial application ("CTA") in its fourth quarter of fiscal 2010, pending timely and successful completion of the Company's planned remaining pre-IND activities.

Topical Interferon Alpha-2b

  • A pre-IND meeting with the FDA was held in which the FDA confirmed the acceptability of a Phase II/III, randomized, vehicle-controlled clinical trial as the next step in the compound's clinical development plan for patients with cervical dysplasia. The Company continues to project that its U.S. Phase II/III IND filing will occur, at the earliest, in its fourth quarter of fiscal 2010, pending timely and successful completion of its remaining pre-IND activities. The FDA also confirmed Helix's expectation that an additional well-controlled, Phase III confirm
    '/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
2. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
3. Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
4. Helix BioPharma Corp. Announces Fiscal 2009 Results
5. Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
9. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
10. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
11. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , 31 juli 2014 De Pfizer ... een rekruteringscampagne voor gezonde vrijwilligers van Japanse komaf voor ... gevestigde PCRU is één van twee onderzoekseenheden ... als ideaal levens te verbeteren door de ontdekking en ... de PCRU op zoek naar mannen en vrouwen van ...
(Date:7/30/2014)... ARBOR, Mich. , July 30, 2014 Advanced ... first quarter (ending June 27, 2014) financial results on Monday, ... will be released after the close of the market and ... discuss the results at 4:30 p.m. EDT on the same ... Richard Kurtz (CEO and Director), Rob Risser ...
(Date:7/30/2014)... , July 30, 2014  Cepheid (Nasdaq: ... group purchasing contract with Premier will end on ... Premier GPO will be able to continue their ... Baycare, HPA, MedAssets, Novation, and ROi, in addition ... directly with Cepheid. "Cepheid has always ...
Breaking Medicine Technology:Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Advanced Photonix to Webcast Fiscal 2015 First Quarter Earnings 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 3
... Aethlon Medical, Inc. (OTC Bulletin Board: ... filtration devices to address infectious disease and cancer, ... entitled: " A Platform to Address Bioterrorism." ... at: http://www.aethlonmedical.com/knowledge-center/special-reports/ ...
... 2010 Northwestern Memorial Hospital is one ... will test whether operable lung cancer patients and their ... by hardwiring data systems to reduce medical error and ... trial co-sponsored by the Commission on Cancer and the ...
Cached Medicine Technology:'A Platform Technology to Address Bioterrorism' Released by Aethlon Medical, Inc. 2'A Platform Technology to Address Bioterrorism' Released by Aethlon Medical, Inc. 3'A Platform Technology to Address Bioterrorism' Released by Aethlon Medical, Inc. 4Lung Cancer Patients the Centerpiece for Northwestern Medicine Quality of Care Study 2Lung Cancer Patients the Centerpiece for Northwestern Medicine Quality of Care Study 3
(Date:7/31/2014)... 31, 2014 The average American drinks ... of $11.8 billion, and this is major cause of ... Institute in Woodland Hills and Oxnard, Calif. , That’s ... fluoride. , “Tap water is almost universally fluoridated,” said ... Institute. “Adding fluoride to municipal water supplies has drastically ...
(Date:7/31/2014)... Eden Lew has been awarded ... Crawford Technologies" Scholarship through EDSF (Electronic ... honor the contributions Chuck Forman made throughout his ... lost his battle with cancer on October 2, ... are thrilled to see her receive the second ...
(Date:7/31/2014)... Parsippany, NJ (PRWEB) July 31, 2014 A ... millions of people survive cancer and resume normal lives. This ... American Cancer Society, will affect one in seven American men ... are, has a five-year survival rate of nearly 100% and ... serious illness but most men diagnosed with the disease do ...
(Date:7/31/2014)... USHIO America’s Solid State Lighting ... lighting marketplaces, today announced the launch of its ... users to transform existing, inefficient lamp-based downlights to ... USHIO America’s Uphoria LED downlight retrofit kits fit ... the user to upgrade old incandescent recessed lighting ...
(Date:7/31/2014)... Upper Marlboro, MD (PRWEB) July 31, 2014 ... names in hair care, from Clairol to Shea Moisture. And ... roster: G’ Natural Herbal Products. Starting August 1, guests will ... , Founded in 1996 with $200 investment, CEO Roger Gore ... that his own hair was thinning and developing a receding ...
Breaking Medicine News(10 mins):Health News:Woodland Hills Top Cosmetic Dentists Offer 5 Tips for Getting More Teeth-Protecting Fluoride 2Health News:Woodland Hills Top Cosmetic Dentists Offer 5 Tips for Getting More Teeth-Protecting Fluoride 3Health News:Woodland Hills Top Cosmetic Dentists Offer 5 Tips for Getting More Teeth-Protecting Fluoride 4Health News:Woodland Hills Top Cosmetic Dentists Offer 5 Tips for Getting More Teeth-Protecting Fluoride 5Health News:Eden Lew Recipient of 2014 EDSF Scholarship Honoring Chuck Forman 2Health News:Eden Lew Recipient of 2014 EDSF Scholarship Honoring Chuck Forman 3Health News:Restoring Intimacy after Prostate Cancer; Dr. Daniel Watter with Morris Psychological Group Offers Tips for Patients and their Partners 2Health News:Restoring Intimacy after Prostate Cancer; Dr. Daniel Watter with Morris Psychological Group Offers Tips for Patients and their Partners 3Health News:Restoring Intimacy after Prostate Cancer; Dr. Daniel Watter with Morris Psychological Group Offers Tips for Patients and their Partners 4Health News:USHIO America Introduces Uphoria™ LED Downlight Retrofit Kits 2Health News:CVS Caremark Adds New, Natural Acclaimed Hair Care Line to its Beauty Roster 2
... International experts say there isn,t enough evidence to prove ... There,s not enough evidence to support a recent American ... for depression, according to international experts who contend the ... without any proof it would improve patient care. , ...
... counters editorial, , , TUESDAY, Nov. 11 (HealthDay News) -- ... strong, these vital nutrients don,t appear to help postmenopausal ... message is that there,s benefit from calcium and vitamin ... be doing much for breast cancer risk. You wouldn,t ...
... Urologychannel.com , a leader in patient education information and marketing services ... Center (OMC). The new Center offers free services to help urologists ... improve their practice website,s search engine presence. , ... ...
... a unique, customized gift,for the animal lover on your Christmas, ... (MAF) that benefits a favorite animal,-- dog, cat, horse or ... on your list. Many people who make a holiday gift ... holiday cards. A donation can be a,wonderful alternative to the ...
... carry cholesterol and triglycerides throughout the body , , TUESDAY, ... particles may increase the risk of high blood pressure ... That,s the conclusion of a new study by U.S. ... the Women,s Health Study. , Lipoprotein particles carry cholesterol ...
... 11 Ken Herron, Chief Marketing,Executive at Online ... that David S. Novak of the Centers for ... at Online Buddies, Inc. as the site,s first ... site for,gay men, with 2,000,000 members worldwide, is ...
Cached Medicine News:Health News:Study Questions Screening Heart Attack Patients for Depression 2Health News:Study Questions Screening Heart Attack Patients for Depression 3Health News:Calcium, Vitamin D Won't Prevent Breast Cancer 2Health News:Calcium, Vitamin D Won't Prevent Breast Cancer 3Health News:Innovative New Program Offers Free Online Services to Urologists 2Health News:Innovative New Program Offers Free Online Services to Urologists 3Health News:Unique Holiday Gift for Animal Lovers: A Donation to Fund Animal Health Research; Pick a Favorite Animal - Dog, Cat, Horse, All Species of Wildlife 2Health News:Lipoprotein Levels May Predict Women's Hypertension Risk 2Health News:MANHUNT Leads Fight Against Spread of Sexually Transmitted Infections with Launch of MANHUNT Cares; Hires Senior Public Health Strategist from CDC 2
Angled 45 degree shafts 8 mm from tip to bend with 5 mm tying platform. Serrated handle with dull finish. Overall length 3.3 inches....
Ultra-fine 5 mm tying platform is valuable when manipulating delicate 10-0 and 11-0 sutures. Pin in handle keeps tips in alignment. Shafts available straight or angled 45 degrees, 8 mm from tip. Stra...
Ultra-fine 5 mm tying platform is valuable when manipulating delicate 10-0 and 11-0 sutures. Pin in handle keeps tips in alignment. Shafts available straight or angled 45 degrees, 8 mm from tip. Angl...
Straight shafts with 4 mm tying platform. Wide serrated handle with dull finish. Overall length 4.3 inches....
Medicine Products: